 | • レポートコード：MRC2-11QY11206 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は気管支肺異形成症のグローバル市場について調査・分析したレポートです。種類別（サーファクタント補充療法、酸素療法、支持療法、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別気管支肺異形成症の競争状況、市場シェア ・世界の気管支肺異形成症市場：種類別市場規模 2015年-2020年（サーファクタント補充療法、酸素療法、支持療法、その他） ・世界の気管支肺異形成症市場：種類別市場規模予測 2021年-2026年（サーファクタント補充療法、酸素療法、支持療法、その他） ・世界の気管支肺異形成症市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の気管支肺異形成症市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の気管支肺異形成症市場分析：米国、カナダ ・ヨーロッパの気管支肺異形成症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの気管支肺異形成症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の気管支肺異形成症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの気管支肺異形成症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Chiesi Farmaceutici、Discovery Laboratories、Takeda Pharmaceutical Company、MediPost、Clarassance、Syntrix Biosystems ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies.
The global bronchopulmonary dysplasia treatment market is expected to expand at a steady CAGR during the forecast period. According to the Journal of Clinical Medicine, 10,000 to 15,000 new cases of the disorder are reported each year in the U.S. alone. High prevalence of the diseases is expected to drive the global bronchopulmonary dysplasia treatment market during the forecast period. According to the WHO, 15 million babies are born preterm which is another factor contributing to the growth of the market. Furthermore, government initiatives, favorable reimbursement policies, launch of novel drugs, strong pipeline, rising premature birth cases, and increase in health care expenditure are factors likely to propel the global bronchopulmonary dysplasia treatment market during the forecast period. Long-term side effects of drugs, high cost of treatment, and lack of awareness in developing countries are factors anticipated to restrain the global market during the forecast period.
Market Analysis and Insights: Global Bronchopulmonary Dysplasia Market
The global Bronchopulmonary Dysplasia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bronchopulmonary Dysplasia Scope and Market Size
Bronchopulmonary Dysplasia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bronchopulmonary Dysplasia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Chiesi Farmaceutici
Discovery Laboratories
Takeda Pharmaceutical Company
MediPost
Clarassance
Syntrix Biosystems
…
Market segment by Type, the product can be split into
Surfactant Replacement Therapy
Oxygen Therapy
Supportive Therapy
Others
Market segment by Application, split into
Clinic
Hospital
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bronchopulmonary Dysplasia Revenue
1.4 Market by Type
1.4.1 Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surfactant Replacement Therapy
1.4.3 Oxygen Therapy
1.4.4 Supportive Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Bronchopulmonary Dysplasia Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bronchopulmonary Dysplasia Market Perspective (2015-2026)
2.2 Global Bronchopulmonary Dysplasia Growth Trends by Regions
2.2.1 Bronchopulmonary Dysplasia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bronchopulmonary Dysplasia Historic Market Share by Regions (2015-2020)
2.2.3 Bronchopulmonary Dysplasia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bronchopulmonary Dysplasia Market Growth Strategy
2.3.6 Primary Interviews with Key Bronchopulmonary Dysplasia Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bronchopulmonary Dysplasia Players by Market Size
3.1.1 Global Top Bronchopulmonary Dysplasia Players by Revenue (2015-2020)
3.1.2 Global Bronchopulmonary Dysplasia Revenue Market Share by Players (2015-2020)
3.1.3 Global Bronchopulmonary Dysplasia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bronchopulmonary Dysplasia Market Concentration Ratio
3.2.1 Global Bronchopulmonary Dysplasia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bronchopulmonary Dysplasia Revenue in 2019
3.3 Bronchopulmonary Dysplasia Key Players Head office and Area Served
3.4 Key Players Bronchopulmonary Dysplasia Product Solution and Service
3.5 Date of Enter into Bronchopulmonary Dysplasia Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bronchopulmonary Dysplasia Historic Market Size by Type (2015-2020)
4.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
5.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bronchopulmonary Dysplasia Market Size (2015-2020)
6.2 Bronchopulmonary Dysplasia Key Players in North America (2019-2020)
6.3 North America Bronchopulmonary Dysplasia Market Size by Type (2015-2020)
6.4 North America Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bronchopulmonary Dysplasia Market Size (2015-2020)
7.2 Bronchopulmonary Dysplasia Key Players in Europe (2019-2020)
7.3 Europe Bronchopulmonary Dysplasia Market Size by Type (2015-2020)
7.4 Europe Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
8 China
8.1 China Bronchopulmonary Dysplasia Market Size (2015-2020)
8.2 Bronchopulmonary Dysplasia Key Players in China (2019-2020)
8.3 China Bronchopulmonary Dysplasia Market Size by Type (2015-2020)
8.4 China Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bronchopulmonary Dysplasia Market Size (2015-2020)
9.2 Bronchopulmonary Dysplasia Key Players in Japan (2019-2020)
9.3 Japan Bronchopulmonary Dysplasia Market Size by Type (2015-2020)
9.4 Japan Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bronchopulmonary Dysplasia Market Size (2015-2020)
10.2 Bronchopulmonary Dysplasia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bronchopulmonary Dysplasia Market Size by Type (2015-2020)
10.4 Southeast Asia Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
11 India
11.1 India Bronchopulmonary Dysplasia Market Size (2015-2020)
11.2 Bronchopulmonary Dysplasia Key Players in India (2019-2020)
11.3 India Bronchopulmonary Dysplasia Market Size by Type (2015-2020)
11.4 India Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bronchopulmonary Dysplasia Market Size (2015-2020)
12.2 Bronchopulmonary Dysplasia Key Players in Central & South America (2019-2020)
12.3 Central & South America Bronchopulmonary Dysplasia Market Size by Type (2015-2020)
12.4 Central & South America Bronchopulmonary Dysplasia Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Chiesi Farmaceutici
13.1.1 Chiesi Farmaceutici Company Details
13.1.2 Chiesi Farmaceutici Business Overview
13.1.3 Chiesi Farmaceutici Bronchopulmonary Dysplasia Introduction
13.1.4 Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2015-2020))
13.1.5 Chiesi Farmaceutici Recent Development
13.2 Discovery Laboratories
13.2.1 Discovery Laboratories Company Details
13.2.2 Discovery Laboratories Business Overview
13.2.3 Discovery Laboratories Bronchopulmonary Dysplasia Introduction
13.2.4 Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2015-2020)
13.2.5 Discovery Laboratories Recent Development
13.3 Takeda Pharmaceutical Company
13.3.1 Takeda Pharmaceutical Company Company Details
13.3.2 Takeda Pharmaceutical Company Business Overview
13.3.3 Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Introduction
13.3.4 Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2015-2020)
13.3.5 Takeda Pharmaceutical Company Recent Development
13.4 MediPost
13.4.1 MediPost Company Details
13.4.2 MediPost Business Overview
13.4.3 MediPost Bronchopulmonary Dysplasia Introduction
13.4.4 MediPost Revenue in Bronchopulmonary Dysplasia Business (2015-2020)
13.4.5 MediPost Recent Development
13.5 Clarassance
13.5.1 Clarassance Company Details
13.5.2 Clarassance Business Overview
13.5.3 Clarassance Bronchopulmonary Dysplasia Introduction
13.5.4 Clarassance Revenue in Bronchopulmonary Dysplasia Business (2015-2020)
13.5.5 Clarassance Recent Development
13.6 Syntrix Biosystems
13.6.1 Syntrix Biosystems Company Details
13.6.2 Syntrix Biosystems Business Overview
13.6.3 Syntrix Biosystems Bronchopulmonary Dysplasia Introduction
13.6.4 Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2015-2020)
13.6.5 Syntrix Biosystems Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bronchopulmonary Dysplasia Key Market Segments
Table 2. Key Players Covered: Ranking by Bronchopulmonary Dysplasia Revenue
Table 3. Ranking of Global Top Bronchopulmonary Dysplasia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surfactant Replacement Therapy
Table 6. Key Players of Oxygen Therapy
Table 7. Key Players of Supportive Therapy
Table 8. Key Players of Others
Table 9. Global Bronchopulmonary Dysplasia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Bronchopulmonary Dysplasia Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Bronchopulmonary Dysplasia Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Bronchopulmonary Dysplasia Market Share by Regions (2015-2020)
Table 13. Global Bronchopulmonary Dysplasia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Bronchopulmonary Dysplasia Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Bronchopulmonary Dysplasia Market Growth Strategy
Table 19. Main Points Interviewed from Key Bronchopulmonary Dysplasia Players
Table 20. Global Bronchopulmonary Dysplasia Revenue by Players (2015-2020) (Million US$)
Table 21. Global Bronchopulmonary Dysplasia Market Share by Players (2015-2020)
Table 22. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchopulmonary Dysplasia as of 2019)
Table 23. Global Bronchopulmonary Dysplasia by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Bronchopulmonary Dysplasia Product Solution and Service
Table 26. Date of Enter into Bronchopulmonary Dysplasia Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 29. Global Bronchopulmonary Dysplasia Market Size Share by Type (2015-2020)
Table 30. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2021-2026)
Table 31. Global Bronchopulmonary Dysplasia Market Size Share by Application (2015-2020)
Table 32. Global Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 33. Global Bronchopulmonary Dysplasia Market Size Share by Application (2021-2026)
Table 34. North America Key Players Bronchopulmonary Dysplasia Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Bronchopulmonary Dysplasia Market Share (2019-2020)
Table 36. North America Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 37. North America Bronchopulmonary Dysplasia Market Share by Type (2015-2020)
Table 38. North America Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 39. North America Bronchopulmonary Dysplasia Market Share by Application (2015-2020)
Table 40. Europe Key Players Bronchopulmonary Dysplasia Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Bronchopulmonary Dysplasia Market Share (2019-2020)
Table 42. Europe Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Bronchopulmonary Dysplasia Market Share by Type (2015-2020)
Table 44. Europe Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Bronchopulmonary Dysplasia Market Share by Application (2015-2020)
Table 46. China Key Players Bronchopulmonary Dysplasia Revenue (2019-2020) (Million US$)
Table 47. China Key Players Bronchopulmonary Dysplasia Market Share (2019-2020)
Table 48. China Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 49. China Bronchopulmonary Dysplasia Market Share by Type (2015-2020)
Table 50. China Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 51. China Bronchopulmonary Dysplasia Market Share by Application (2015-2020)
Table 52. Japan Key Players Bronchopulmonary Dysplasia Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Bronchopulmonary Dysplasia Market Share (2019-2020)
Table 54. Japan Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Bronchopulmonary Dysplasia Market Share by Type (2015-2020)
Table 56. Japan Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Bronchopulmonary Dysplasia Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Bronchopulmonary Dysplasia Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Bronchopulmonary Dysplasia Market Share (2019-2020)
Table 60. Southeast Asia Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Bronchopulmonary Dysplasia Market Share by Type (2015-2020)
Table 62. Southeast Asia Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Bronchopulmonary Dysplasia Market Share by Application (2015-2020)
Table 64. India Key Players Bronchopulmonary Dysplasia Revenue (2019-2020) (Million US$)
Table 65. India Key Players Bronchopulmonary Dysplasia Market Share (2019-2020)
Table 66. India Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 67. India Bronchopulmonary Dysplasia Market Share by Type (2015-2020)
Table 68. India Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 69. India Bronchopulmonary Dysplasia Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Bronchopulmonary Dysplasia Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Bronchopulmonary Dysplasia Market Share (2019-2020)
Table 72. Central & South America Bronchopulmonary Dysplasia Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Bronchopulmonary Dysplasia Market Share by Type (2015-2020)
Table 74. Central & South America Bronchopulmonary Dysplasia Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Bronchopulmonary Dysplasia Market Share by Application (2015-2020)
Table 76. Chiesi Farmaceutici Company Details
Table 77. Chiesi Farmaceutici Business Overview
Table 78. Chiesi Farmaceutici Product
Table 79. Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2015-2020) (Million US$)
Table 80. Chiesi Farmaceutici Recent Development
Table 81. Discovery Laboratories Company Details
Table 82. Discovery Laboratories Business Overview
Table 83. Discovery Laboratories Product
Table 84. Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2015-2020) (Million US$)
Table 85. Discovery Laboratories Recent Development
Table 86. Takeda Pharmaceutical Company Company Details
Table 87. Takeda Pharmaceutical Company Business Overview
Table 88. Takeda Pharmaceutical Company Product
Table 89. Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2015-2020) (Million US$)
Table 90. Takeda Pharmaceutical Company Recent Development
Table 91. MediPost Company Details
Table 92. MediPost Business Overview
Table 93. MediPost Product
Table 94. MediPost Revenue in Bronchopulmonary Dysplasia Business (2015-2020) (Million US$)
Table 95. MediPost Recent Development
Table 96. Clarassance Company Details
Table 97. Clarassance Business Overview
Table 98. Clarassance Product
Table 99. Clarassance Revenue in Bronchopulmonary Dysplasia Business (2015-2020) (Million US$)
Table 100. Clarassance Recent Development
Table 101. Syntrix Biosystems Company Details
Table 102. Syntrix Biosystems Business Overview
Table 103. Syntrix Biosystems Product
Table 104. Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2015-2020) (Million US$)
Table 105. Syntrix Biosystems Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchopulmonary Dysplasia Market Share by Type: 2020 VS 2026
Figure 2. Surfactant Replacement Therapy Features
Figure 3. Oxygen Therapy Features
Figure 4. Supportive Therapy Features
Figure 5. Others Features
Figure 6. Global Bronchopulmonary Dysplasia Market Share by Application: 2020 VS 2026
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. Bronchopulmonary Dysplasia Report Years Considered
Figure 11. Global Bronchopulmonary Dysplasia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bronchopulmonary Dysplasia Market Share by Regions: 2020 VS 2026
Figure 13. Global Bronchopulmonary Dysplasia Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bronchopulmonary Dysplasia Market Share by Players in 2019
Figure 16. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchopulmonary Dysplasia as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bronchopulmonary Dysplasia Revenue in 2019
Figure 18. North America Bronchopulmonary Dysplasia Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bronchopulmonary Dysplasia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Bronchopulmonary Dysplasia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Bronchopulmonary Dysplasia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Bronchopulmonary Dysplasia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Bronchopulmonary Dysplasia Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Bronchopulmonary Dysplasia Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
気管支肺異形成症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Bronchopulmonary Dysplasia Drug Market The global Bronchopulmonary Dysplasia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bronchopulmonary Dysplasia Drug Scope and Market Si…- 子宮頸部異形成の世界市場（～2026年） Cervical dysplasia is a precancerous condition in which abnormal cell growth occurs on the surface lining of the cervix or endocervical canal, the opening between the uterus and the vagina. It is also called cervical intraepithelial neoplasia (CIN). Market Analysis and Insights: Global Cervical Dysp…
- 子宮頸部異形成治療の世界市場（～2026年） A precancerous condition where abnormal cell growth occurs at the opening of the cervix is known as cervical dysplasia. Alternatively, it is known as cervical intraepithelial neoplasia. This disease affects the women of all ages but occurs commonly in the age group of 25 to 35 years old. The cervica…
- 酸素療法装置の世界市場（～2026年） Oxygen therapy, also known as supplemental oxygen, is the use of oxygen as a medical treatment. This can include for low blood oxygen, carbon monoxide toxicity, cluster headaches, and to maintain enough oxygen while inhaled anesthetics are given. Long term oxygen is often useful in people with chron…
- 血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…